The purpose of this study was to assess further the effect of amphetam
ine on negative symptoms of schizophrenia. Thirty-seven schizophrenic
males meeting DSM-III criteria were rated with the Brief Psychiatric R
ating Scale, the Abrams and Taylor Scale, and the Abnormal Involuntary
Movements Scale before and after double-blind administration of eithe
r amphetamine (n = 26) or placebo (n = 11). Our results indicated that
amphetamine administration generally did not improve negative symptom
s, even when accounting for changes in positive symptoms. However, gre
ater baseline negative symptoms were associated with a modest diminuti
on after amphetamine treatment. Therefore, amphetamine may modestly im
prove negative symptoms in those schizophrenics in whom this symptomat
ology is more severe.